References
- Ballinger WF, Lacy PE. Transplantation of intact pancreatic islets in rats. Surgery 1972; 72: 175-86. PMID: 4262169
- Kemp CB, Knight MJ, Scharp DW, Ballinger WF, Lacy PE. Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats. Diabetologia 1973; 9: 486-91. doi: 10.1007/BF00461694
- Shapiro AJ, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318-30. doi: 10.1056/NEJMoa061267
- McCall M, Shapiro AJ. Update on islet transplantation. Cold Spring Harb Perspect Med 2012; 2: a007823. doi: 10.1101/cshperspect.a007823
- Korsgren O, Nilsson B, Berne C, Felldin M, Foss A, Kallen R, et al. Current status of clinical islet transplantation. Transplantation 2005; 79: 1289-93. doi: 10.1097/01.tp.0000157273.60147.7c
- Biarnés M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. β-cell death and mass in syngeneically transplanted islets exposed to short-and long-term hyperglycemia. Diabetes 2002; 51: 66-72. doi: 10.2337/diabetes.51.1.66
- Bennet W, Groth CG, Larsson R, Nilsson B, Korsgren O. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for in-traportal islet transplantation as a treatment for patients with type 1 diabetes. Upsala J Med Sci 2000; 105: 125-33. doi: 10.1517/03009734000000059
- Silva IB, Kimura CH, Colantoni VP, Sogayar MC. Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges. Stem Cell Res Ther 2022; 13: 1-24. doi: 10.1186/s13287-022-02977-y
- Cayabyab F, Nih LR, Yoshihara E. Advances in pancreatic islet transplantation sites for the treatment of diabetes. Front Endocrinol 2021: 12: 732431. doi: 10.3389/fendo.2021.732431
- Rickels MR, Robertson RP. Pancreatic islet transplantation in humans: recent progress and future directions. Endocr Rev 2019; 40: 631-68. doi: 10.1210/ er.2018-00154
- Fujita I, Utoh R, Yamamoto M, Okano T, Yamato M. The liver surface as a favorable site for islet cell sheet transplantation in type 1 diabetes model mice. Regen Ther 2018; 8: 65-72. doi: 10.1016/j.reth.2018.04.002
- Koethe Y, Wilson N, Narayanan G. Irreversible electroporation for colorectal cancer liver metastasis: a review. Int J Hyperthermia 2022; 39: 682-7. doi: 10.1080/02656736.2021.2008025
- Davalos RV, Mir LM, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005; 33: 223-31. doi: 10.1007/s10439-005-8981-8
- Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 2007; 6: 37-48. doi: 10.1177/153303460700600106
- Al-Sakere B, André F, Bernat C, Connault E, Opolon P, Davalos RV, et al. Tumor ablation with irreversible electroporation. PloS ONE 2007; 2: e1135. doi: 10.1371/journal.pone.0001135
- Zhang Y, Lyu C, Liu Y, Lv Y, Chang TT, Rubinsky B. Molecular and histological study on the effects of non-thermal irreversible electroporation on the liver. Biochem Biophys Res Commun 2018; 500: 665-70. doi: 10.1016/j. bbrc.2018.04.132
- Phillips MA, Narayan R, Padath T, Rubinsky B. Irreversible electroporation on the small intestine. Br J Cancer 2012; 106: 490-5. doi: 10.1038/bjc.2011.582
- Hitpass L, Distelmaier M, Neumann UP, Schöning W, Isfort P, Keil S, et al. Recurrent colorectal liver metastases in the liver remnant after major liver surgery – IRE as a salvage local treatment when resection and thermal ablation are unsuitable. Cardiovasc Intervent Radiol 2022; 45: 182-9. doi: 10.1007/s00270-021-02981-4
- Lee EW, Shahrouki P, Peterson S, Tafti BA, Ding PX, Kee ST. Safety of irreversible electroporation ablation of the pancreas. Pancreas 2021; 50: 1281-6. doi: 10.1097/MPA.0000000000001916
- Maor E, Ivorra A, Mitchell JJ, Rubinsky B. Vascular smooth muscle cells ablation with endovascular nonthermal irreversible electroporation. J Vasc Interv Radiol 2010; 21: 1708-15. doi: 10.1016/j.jvir.2010.06.024
- Maor E, Ivorra A, Leor J, Rubinsky B. Irreversible electroporation attenuates neointimal formation after angioplasty. IEEE Trans Biomed Eng 2008; 55: 2268-74. doi: 10.1109/TBME.2008.923909
- Phillips M, Maor E, Rubinsky B. Principles of tissue engineering with non-thermal irreversible electroporation. J Heat Transfer 2011; 133: 011004. doi: 10.1115/1.4002301.
- Phillips M, Maor E, Rubinsky B. Nonthermal irreversible electroporation for tissue decellularization. J Biomech Eng 2010; 132: 091003. doi: 10.1115/1.4001882
- Phillips M, Maor E, Rubinsky B. Lavee J. Extracellular matrix material created using non-thermal irreversible electroporation. US Patent 08835166, Sep 16 2014.
- Chang TT, Zhou VX, Rubinsky B. Using non-thermal irreversible electroporation to create an in vivo niche for exogenous cell engraftment. Biotechniques 2017; 62: 229-31. doi: 10.2144/000114547
- Lopez-Ichikawa M, Vu NK, Nijagal A, Rubinsky B, Chang TT. Neutrophils are important for the development of pro-reparative macrophages after irreversible electroporation of the liver in mice. Sci Rep 2021; 11: 1-3. doi: 10.1038/s41598-021-94016-8
- Zhou VX, Lolas M, Chang TT. Direct orthotopic implantation of hepatic organoids. J. Surg. Res 2017; 211: 251-60. doi: 10.1016/j.jss.2016.12.028
- Szot GL, Koudria P, Bluestone JA. Murine pancreatic islet isolation. J Vis Exp 2007; 22: e255. doi: 10.3791/255
- Michalopoulos GK. Liver regeneration. J. Cell. Physiol 2007; 213: 286-300. doi: 10.1002/jcp.21172